Krilogy Financial LLC Corcept Therapeutics Inc Transaction History

Krilogy Financial LLC

  • $1.37 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$11.29 - $17.19 $2,258 - $3,438
-200 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$12.27 - $15.65 $2,454 - $3,130
200 New
200 $3,000
Q2 2018

Aug 15, 2018
SELL
$15.3 - $19.69 $3,060 - $3,938
-200 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$14.59 - $25.5 $2,918 - $5,100
200 New
200 $3,000

Others Institutions Holding CORT

# of Institutions
403
Shares Held
84.3M
Call Options Held
1.04M
Put Options Held
1.33M
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.81B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Krilogy Financial LLC Portfolio

Follow Krilogy Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krilogy Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email